Trending Content - Investment Banking Forum
| +183 | Evercore > Goldman and I don’t think it’s particularly close anymore | 65 | 6h |
| +157 | Article: Why UBS's Asian M&A bankers are thriving and UBS's American M&A bankers are not | 17 | 1d |
| +87 | UBS Offer Day | 30 | 1d |
| +86 | Santander IB? | 10 | 3d |
| +71 | I hate Wells Fargo | 19 | 1d |
| +67 | Think Twice before Recruiting for HOUSTON IB!! | 36 | 1h |
| +51 | No return offer - feeling like a failure is an understatement | 20 | 19h |
| +49 | How cooked am I as an incoming WF IB SA 2027? | 17 | 21h |
| +46 | WF Return offers | 28 | 2d |
| +40 | 2026 Investment Banking Return Offer Climate | 25 | 1d |
Career Resources
Restructuring - you would get direct experience in OOC and Ch 11 bankruptcies
bump. Is the transition easy/possible from a low-tier RX IB (JEF/Baird/Piper)?
Don't have a direct answer to your question, but for context, even coming from an RX consulting background, you'll most likely get looks from distressed shops, especially in this market.
Do you have any stats behind that? I’m an AN1 RX consultant at A&M and haven’t seen any real exits (saw one post MBA associate go to a BB as an assoc1) but no distressed exits. Seems like all buy side opportunities want IB if not RX IB. Happy to hear a counter argument. Currently weighing A&M RX or one of the low tier RX IBs mentioned above for reference and looking to do distressed buy side in the future.
Et quia praesentium dolore aliquam. Qui laboriosam incidunt sunt. Eos eveniet ad dicta quisquam inventore delectus. Voluptas amet sed velit adipisci pariatur sit mollitia. Sed qui est velit.
Impedit non sed laudantium et. Neque officiis eum incidunt a illo. Magni hic magni corporis dolorum tempora ut. Et sed dignissimos architecto similique inventore.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...